PRT-2761

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePRT-2761
Drug Alias NamePRT-2761
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPortola Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOra Inc
Active IndicationsN/A
Inactive IndicationsConjunctivitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A